false
Catalog
Adherence to Antipsychotics in Schizophrenia: Clin ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document titled "Adherence to Antipsychotics in Schizophrenia: Clinical Considerations" highlights the importance of medication adherence in individuals with schizophrenia. The document provides information on various factors that contribute to poor adherence, including lack of insight, poor drug attitude, barriers to adherence, and non-compliance behavior. It emphasizes the impact of non-adherence on relapse rates, psychosocial toxicity, and overall treatment outcomes.<br /><br />The document outlines different methods for assessing adherence, such as evaluating drug attitude, assessing barriers to adherence, and monitoring compliance behavior. It discusses the benefits and limitations of various assessment techniques, including self-report, collateral information, pill count, pharmacy records, therapeutic drug monitoring, and digital medicine.<br /><br />The document also presents strategies for enhancing adherence. It emphasizes the importance of a multi-pronged approach that includes patient-centered strategies (strengthening alliance, psychoeducation, shared decision making), environment-centered strategies (support and supervision), and treatment-centered strategies (simplifying the regimen, addressing tolerability, considering long-acting injectable antipsychotics).<br /><br />Furthermore, the document addresses the societal context and risks associated with digital adherence monitoring. It highlights the need for patient selection, the challenges faced by paranoid patients, and the potential risks to medical privacy and healthcare disparities.<br /><br />In conclusion, this document provides valuable insights into the clinical considerations of adherence to antipsychotics in schizophrenia. It emphasizes the need for comprehensive assessment methods and a personalized approach to enhance adherence and improve treatment outcomes in individuals with schizophrenia.
Keywords
Antipsychotics
Schizophrenia
Medication adherence
Factors contributing to poor adherence
Assessing adherence
Methods for assessing adherence
Enhancing adherence strategies
Patient-centered strategies
Environment-centered strategies
Treatment-centered strategies
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English